Tiaa Fsb bought a new stake in shares of Stryker Corporation (NYSE:SYK) in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor bought 57,429 shares of the medical technology company’s stock, valued at approximately $7,970,000.

A number of other large investors have also recently added to or reduced their stakes in SYK. Acrospire Investment Management LLC acquired a new stake in shares of Stryker Corporation during the 2nd quarter worth approximately $111,000. Bollard Group LLC grew its position in shares of Stryker Corporation by 0.4% during the 2nd quarter. Bollard Group LLC now owns 832 shares of the medical technology company’s stock worth $115,000 after buying an additional 3 shares during the period. Motco grew its position in shares of Stryker Corporation by 50.7% during the 2nd quarter. Motco now owns 826 shares of the medical technology company’s stock worth $115,000 after buying an additional 278 shares during the period. Bruderman Asset Management LLC acquired a new stake in shares of Stryker Corporation during the 2nd quarter worth approximately $150,000. Finally, James Investment Research Inc. acquired a new stake in shares of Stryker Corporation during the 2nd quarter worth approximately $155,000. 74.13% of the stock is owned by institutional investors and hedge funds.

Several brokerages have recently commented on SYK. Cowen and Company set a $160.00 price objective on shares of Stryker Corporation and gave the stock a “buy” rating in a research report on Friday, October 6th. Royal Bank Of Canada reaffirmed a “buy” rating and set a $155.00 price objective on shares of Stryker Corporation in a research report on Monday, October 2nd. SunTrust Banks, Inc. reaffirmed a “buy” rating and set a $161.00 price objective on shares of Stryker Corporation in a research report on Monday, October 2nd. Argus reaffirmed a “buy” rating and set a $160.00 price objective on shares of Stryker Corporation in a research report on Tuesday, August 29th. Finally, BidaskClub downgraded shares of Stryker Corporation from a “buy” rating to a “hold” rating in a research report on Saturday, August 26th. Two equities research analysts have rated the stock with a sell rating, nine have assigned a hold rating and twelve have given a buy rating to the company. The company has a consensus rating of “Hold” and an average target price of $146.78.

COPYRIGHT VIOLATION WARNING: “Tiaa Fsb Buys Shares of 57,429 Stryker Corporation (SYK)” was originally published by Watch List News and is the property of of Watch List News. If you are viewing this piece on another publication, it was stolen and republished in violation of international copyright and trademark law. The original version of this piece can be viewed at https://www.watchlistnews.com/tiaa-fsb-buys-shares-of-57429-stryker-corporation-syk/1627608.html.

Stryker Corporation (NYSE:SYK) opened at 146.56 on Friday. The company has a market capitalization of $54.82 billion, a PE ratio of 32.71 and a beta of 0.80. Stryker Corporation has a one year low of $106.48 and a one year high of $149.23. The company has a 50 day moving average price of $142.74 and a 200-day moving average price of $140.38.

Stryker Corporation (NYSE:SYK) last issued its quarterly earnings results on Thursday, July 27th. The medical technology company reported $1.53 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $1.51 by $0.02. The company had revenue of $3.01 billion for the quarter, compared to analysts’ expectations of $2.98 billion. Stryker Corporation had a return on equity of 24.26% and a net margin of 14.22%. The firm’s revenue for the quarter was up 6.1% on a year-over-year basis. During the same period in the prior year, the firm earned $1.39 earnings per share. Analysts expect that Stryker Corporation will post $6.45 EPS for the current fiscal year.

The company also recently declared a quarterly dividend, which will be paid on Tuesday, October 31st. Investors of record on Friday, September 29th will be paid a $0.425 dividend. The ex-dividend date is Thursday, September 28th. This represents a $1.70 annualized dividend and a yield of 1.16%. Stryker Corporation’s payout ratio is 37.95%.

In related news, insider Graham A. Mclean sold 1,124 shares of the company’s stock in a transaction on Tuesday, August 8th. The stock was sold at an average price of $146.26, for a total value of $164,396.24. Following the sale, the insider now directly owns 8,983 shares of the company’s stock, valued at $1,313,853.58. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, insider Lonny J. Carpenter sold 5,000 shares of the company’s stock in a transaction on Friday, August 4th. The stock was sold at an average price of $146.36, for a total value of $731,800.00. Following the completion of the sale, the insider now directly owns 88,207 shares in the company, valued at $12,909,976.52. The disclosure for this sale can be found here. 7.40% of the stock is owned by corporate insiders.

Stryker Corporation Profile

Stryker Corporation is a medical technology company. The Company offers a range of medical technologies, including orthopedic, medical and surgical, and neurotechnology and spine products. The Company’s segments include Orthopaedics; MedSurg; Neurotechnology and Spine, and Corporate and Other. The Orthopaedics segment includes reconstructive (hip and knee) and trauma implant systems and other related products.

Institutional Ownership by Quarter for Stryker Corporation (NYSE:SYK)

Receive News & Ratings for Stryker Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stryker Corporation and related companies with Analyst Ratings Network's FREE daily email newsletter.